Importation
Pharmacists Association Director Warns That Prescription Importation Undermines the Fight Against Opioids
Oklahoma Pharmacists Association Director Debra Billingsley published an editorial on October 21, 2017 opposing drug importation proposals:
Now is not the time to allow foreign unlicensed pharmacies to start dispensing drugs into Oklahoma. It would just make it easier for drug traffickers or crooked providers to hurt our citizens.
[...]Senate HELP Asks Do We Want to Bypass the FDA Gold-Standard of Drug Approvals with Importation?
Every panelist unequivocally stated their opposition to drug importation proposals, citing the danger to patients an unregulated drug supply chain would expose them to. Three, in particular, made cogent arguments on behalf of patient safety and drug accessibility.
[...]Retail Association of Nevada Exec: drug importation puts Americans lives at risk
In her October 18, 2017 editorial for the Las Vegas Sun, Liz MacMenamin, vice president of government affairs for the Retail Association of Nevada, offers facts about drug importation:
Though this may appear as a simple and innocent fix to the problem of high drug prices, the reality is starkly different. Importation threatens the safety of all Americans and the security of the United States’ airtight pharmaceutical quality control system.
[...]PSM’s President Weighs in on Importation Fueling Fentanyl Epidemic
As PSM’s Board President, Dr. Marv Shepherd, wrote in an editorial for the Washington Examiner that was published on October 10, 2017, opening the United States to unregulated, imported drugs will offer fentanyl traffickers even more access to Americans:
“The reality is that criminals throughout the illegal supply chain from China to the streets of U.S. cities are making money at the cost of American lives. We need to be taking steps to eliminate illegal fentanyl from our communities, not providing new avenues for those who want to see just the opposite happen.”
[...]Former Assemblyman Reminds Everyone That Drug Importation Is Bad For Alaska
Paul Honeman is a former Anchorage Assemblyman representing East Anchorage. He also is a retired Anchorage Police Department Lieutenant. In this September 28, 2017 editorial in The Bristol Bay Times, he highlights the dangers posed by drug importation and reminds everyone why it is currently banned…
[...]Separating fact from fiction about drug importation at CNN’s recent Healthcare Town Hall
CNN’s September 25, 2017 Healthcare Town Hall was an opportunity for prominent senators to share important ideas about ways to improve Americans’ lives, but it also included some erroneous statements about drug importation. PSM’s Board President, Dr. Marv Shepherd, sent this letter on September 29 to clarify those issues.
[...]NV Sheriffs’ and Chiefs’ Association Tells Sen. Heller They Oppose Allowing Drug Importation
The Nevada Sheriffs’ and Chiefs’ Association sent a letter to Senator Heller explaining their reasons for opposing S. 469, the bill that would allow drug importation…
[...]Texas Policy Analyst Questions Economic Impact and Safety of Drug Importation
Russell Withers, general counsel at the Texas Conservative Coalition Research Institute in Austin, believes that drug importation is “neither affordable nor safe.” In a September 20, 2017 editorial in the Austin-American Statesman , he argues that “it would hurt U.S. and Texas businesses, workers and patients’ and urges Texan congress members to oppose it.
[...]US Will Be Exposed to Counterfeits From Weak European Drug Security Warns Expert
In early July, European authorities reported that counterfeit versions of Omnitrope, a drug containing human growth hormone, were found in France, Denmark, and Mexico. The counterfeit Omnitrope was designed to look like it was made by a large drug manufacturer, but it contained no active ingredient. Shortly thereafter, German authorities announced that a fake version of a schizophrenia drug, Xeplion, was discovered in Germany. The Xeplion was also a knock-off, mimicking packaging used in Bulgaria and Romania.
These incidents are the latest in a stream of reports about counterfeit drugs throughout Europe. The problem lies in lax security of the supply chain — distributors, middlemen and wholesalers between the drug maker and the consumer. Despite ongoing problems with the EU drug supply chain, Congress is currently considering a bill that would open the U.S. to imports from the EU and elsewhere. We can’t have a serious debate about drug importation without understanding what is going on in Europe.
[...]National Boards of Pharmacy Finds only 4.2% of Online Pharmacies Are Safe
The National Association of Boards of Pharmacy (NABP) has just released their Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: August 2017, outlining the current state of fake online pharmacies that sell to U.S. patients.
Out of 11,688 Internet drug outlets reviewed, the NABP found that 11,142 (95.8%) were “operating out of compliance with state and federal laws and/or NABP patient safety and pharmacy standard practices.”
[...]